Strikingly, when comparing WWOX protein expression in vivo in WT and KC mice at normal acinar sites, levels were found to increase following KRAS activation, as assessed by immunohistochemistry (IHC) staining at 1- and 2-week post-tamoxifen injection (Fig. 2A). The gene discussed is KRAS; the disease is keratoconus.